Suppr超能文献

儿童早期接触扑热息痛和抗生素与哮喘风险增加有关。

Exposure to paracetamol and antibiotics in early life and elevated risk of asthma in childhood.

机构信息

Department of Life Sciences, University of Coimbra, Apartado 3046, 3001-401, Coimbra, Portugal,

出版信息

Adv Exp Med Biol. 2013;788:393-400. doi: 10.1007/978-94-007-6627-3_53.

Abstract

Prospective studies on increased risk of childhood asthma due to exposure to paracetamol and antibiotics in early life have yielded contradictory results. Therefore, the aim of the present study was to investigate the association between administration of paracetamol and antibiotics in the first 12 months of life and delayed asthma symptoms later in childhood. This is a cross-sectional study that included 1,063 children from the primary schools in Coimbra, Portugal. ISAAC-based environmental and core asthma and rhinitis questionnaires were used to obtain information about children's respiratory health and administration of paracetamol and antibiotics. We found that early paracetamol use significantly increased the risk of asthma ever (at least one episode in life) (OR = 2.9; 95 %CI:1.8-4.5), current asthma (OR = 2.4; 95 %CI:1.5-3.6), wheezing ever (OR = 2.5; 95 %CI:1.8-3.4), rhinitis ever (OR = 2.4; 95 %CI:1.7-3.3), and current rhinitis (OR = 2.8; 95 %CI:2.0-3.9). Antibiotic exposure showed a similar effect with the risk for current asthma (OR = 1.6; 95 %CI:1.0-2.5), asthma ever (OR = 2.0; 95 %CI:1.3-3.1), wheeze ever (OR = 2.3; 95 %CI:1.7-3.2), and rhinitis symptoms (OR = 1.8; 95 %CI:1.3-2.6, OR = 1.8; 95 %CI:1.3-2.6, OR = 1.9; 95 %CI:1.2-3.0 for rhinitis ever, current rhinitis, and tearing, respectively). We further found that increased frequency of paracetamol use during the last 12 months preceding the study facilitated the appearance of allergic symptoms, suggesting a dose-dependent associations. In conclusion, the study shows a significant association between exposure to paracetamol and antibiotics in the first 12 months of life and both prevalence and severity of asthma and rhinitis symptoms in children 5-9 years old.

摘要

前瞻性研究表明,生命早期接触扑热息痛和抗生素会增加儿童哮喘的风险,但研究结果相互矛盾。因此,本研究旨在调查生命最初 12 个月内使用扑热息痛和抗生素与儿童后期迟发性哮喘症状之间的关联。这是一项横断面研究,纳入了葡萄牙科英布拉市小学的 1063 名儿童。使用基于 ISAAC 的环境和核心哮喘及鼻炎调查问卷获取有关儿童呼吸健康以及扑热息痛和抗生素使用情况的信息。我们发现,早期使用扑热息痛会显著增加哮喘发作的风险(一生中至少发作一次)(OR = 2.9;95%CI:1.8-4.5)、当前哮喘(OR = 2.4;95%CI:1.5-3.6)、喘息发作(OR = 2.5;95%CI:1.8-3.4)、鼻炎发作(OR = 2.4;95%CI:1.7-3.3)和当前鼻炎(OR = 2.8;95%CI:2.0-3.9)。抗生素暴露也有类似的效果,与当前哮喘(OR = 1.6;95%CI:1.0-2.5)、哮喘发作(OR = 2.0;95%CI:1.3-3.1)、喘息发作(OR = 2.3;95%CI:1.7-3.2)和鼻炎症状(OR = 1.8;95%CI:1.3-2.6)的风险相关。我们进一步发现,在研究前的最后 12 个月内增加扑热息痛的使用频率会促进过敏症状的出现,提示存在剂量依赖性关联。综上所述,该研究表明,生命最初 12 个月内接触扑热息痛和抗生素与 5-9 岁儿童的哮喘和鼻炎症状的患病率和严重程度显著相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验